Literature DB >> 33237361

Beyond physiotherapy and pharmacological treatment for fibromyalgia syndrome: tailored tACS as a new therapeutic tool.

Laura Bernardi1, Margherita Bertuccelli2,3, Emanuela Formaggio1, Maria Rubega1, Gerardo Bosco4, Elena Tenconi5, Manuela Cattelan6, Stefano Masiero1,7, Alessandra Del Felice1,7.   

Abstract

Fibromyalgia syndrome (FMS) is a complex pain disorder, characterized by diffuse pain and cognitive disturbances. Abnormal cortical oscillatory activity may be a promising biomarker, encouraging non-invasive neurostimulation techniques as a treatment. We aimed to modulate abnormal slow cortical oscillations by delivering transcranial alternating current stimulation (tACS) and physiotherapy to reduce pain and cognitive symptoms. This was a double-blinded, randomized, crossover trial conducted between February and September 2018 at the Rehabilitation Unit of a teaching Hospital (NCT03221413). Participants were randomly assigned to tACS or random noise stimulation (RNS), 5 days/week for 2 weeks followed by ad hoc physiotherapy. Clinical and cognitive assessments were performed at T0 (baseline), T1 (after stimulation), T2 (1 month after stimulation). Electroencephalogram (EEG) spectral topographies recorded from 15 participants confirmed slow-rhythm prevalence and provided tACS tailored stimulation parameters and electrode sites. Following tACS, EEG alpha1 ([8-10] Hz) activity increased at T1 (p = 0.024) compared to RNS, pain symptoms assessed by Visual Analog Scale decreased at T1 (T1 vs T0 p = 0.010), self-reported cognitive skills and neuropsychological scores improved both at T1 and T2 (Patient-Reported Outcomes in Cognitive Impairment, T0-T2, p = 0.024; Everyday memory questionnaire, T1 compared to RNS, p = 0.012; Montréal Cognitive Assessment, T0 vs T1, p = 0.048 and T0 vs T2, p = 0.009; Trail Making Test B T0-T2, p = 0.034). Psychopathological scales and other neuropsychological scores (Trail Making Test-A; Total Phonemic Fluency; Hopkins Verbal Learning Test-Revised; Rey-Osterrieth Complex Figure) improved both after tACS and RNS but earlier improvements (T1) were registered only after tACS. These results support tACS coupled with physiotherapy in treating FMS cognitive symptoms, pain and subclinical psychopathology.

Entities:  

Keywords:  Fibrofog; Non-invasive transcranial stimulation; Pain; Random noise stimulation (RNS); Rehabilitation

Mesh:

Year:  2020        PMID: 33237361      PMCID: PMC7867558          DOI: 10.1007/s00406-020-01214-y

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  44 in total

1.  Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia.

Authors:  Jennifer M Glass; David A Williams; Maria-Luisa Fernandez-Sanchez; Anson Kairys; Paloma Barjola; Mary M Heitzeg; Daniel J Clauw; Tobias Schmidt-Wilcke
Journal:  J Pain       Date:  2011-09-25       Impact factor: 5.820

2.  Cognitive functioning in fibromyalgia: The central role of effort.

Authors:  Tamar Bar-On Kalfon; Gilad Gal; Ran Shorer; Jacob N Ablin
Journal:  J Psychosom Res       Date:  2016-06-07       Impact factor: 3.006

Review 3.  Fibrofog and fibromyalgia: a narrative review and implications for clinical practice.

Authors:  Howard M Kravitz; Robert S Katz
Journal:  Rheumatol Int       Date:  2015-01-13       Impact factor: 2.631

4.  Working memory performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain-cognition interaction.

Authors:  R Luerding; T Weigand; U Bogdahn; T Schmidt-Wilcke
Journal:  Brain       Date:  2008-09-26       Impact factor: 13.501

Review 5.  Cognitive impairment in fibromyalgia.

Authors:  Paulo Henrique Ferreira Bertolucci; Fabricio Ferreira de Oliveira
Journal:  Curr Pain Headache Rep       Date:  2013-07

6.  Functional imaging of pain in patients with primary fibromyalgia.

Authors:  Dane B Cook; Gudrun Lange; Donald S Ciccone; Wen-Ching Liu; Jason Steffener; Benjamin H Natelson
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

7.  Brain activity associated with slow temporal summation of C-fiber evoked pain in fibromyalgia patients and healthy controls.

Authors:  Roland Staud; Jason G Craggs; William M Perlstein; Michael E Robinson; Donald D Price
Journal:  Eur J Pain       Date:  2008-03-25       Impact factor: 3.931

Review 8.  Neurobiology of fibromyalgia and chronic widespread pain.

Authors:  Kathleen A Sluka; Daniel J Clauw
Journal:  Neuroscience       Date:  2016-06-09       Impact factor: 3.590

Review 9.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

10.  Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia.

Authors:  Markus Burgmer; Markus Gaubitz; Carsten Konrad; Marco Wrenger; Sebastian Hilgart; Gereon Heuft; Bettina Pfleiderer
Journal:  Psychosom Med       Date:  2009-05-04       Impact factor: 4.312

View more
  3 in total

Review 1.  Non-invasive Brain Stimulation for Chronic Pain: State of the Art and Future Directions.

Authors:  Huan-Yu Xiong; Jie-Jiao Zheng; Xue-Qiang Wang
Journal:  Front Mol Neurosci       Date:  2022-05-26       Impact factor: 6.261

2.  Reply to Letter "Transcranial alternating current stimulation (tACS) as a treatment for fibromyalgia syndrome?" by Fröhlich and Riddle.

Authors:  Alessandra Del Felice; Margherita Bertuccelli; Maria Rubega; Manuela Cattelan; Stefano Masiero
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-05-17       Impact factor: 5.270

3.  Transcranial alternating current stimulation (tACS) as a treatment for fibromyalgia syndrome?

Authors:  Flavio Frohlich; Justin Riddle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-03-13       Impact factor: 5.760

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.